Literature DB >> 3512833

Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a non-specific phenomenon.

A M Verweij-van Vught, F Namavar, W A Vel, M Sparrius, D M MacLaren.   

Abstract

The virulence of Bacteroides fragilis and B. vulgatus for mice was compared in a skin-infection model. These strains were also tested for pathogenic synergy in mixed infections with Escherichia coli. Strains of B. fragilis were generally more virulent than strains of B. vulgatus and, with one exception, the effect of Bacteroides strains in mixed infections merely reflected their inherent virulence.

Entities:  

Mesh:

Year:  1986        PMID: 3512833     DOI: 10.1099/00222615-21-1-43

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Synergy in polymicrobial infections in a mouse model of type 2 diabetes.

Authors:  Matthew D Mastropaolo; Nicholas P Evans; Meghan K Byrnes; Ann M Stevens; John L Robertson; Stephen B Melville
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.

Authors:  Ben R Otto; Silvy J M van Dooren; Charles M Dozois; Joen Luirink; Bauke Oudega
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake.

Authors:  B R Otto; M Sparrius; A M Verweij-van Vught; D M MacLaren
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Roles of porphyrins and host iron transport proteins in regulation of growth of Porphyromonas gingivalis W50.

Authors:  T E Bramanti; S C Holt
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

5.  Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilis.

Authors:  B R Otto; W R Verweij; M Sparrius; A M Verweij-van Vught; C E Nord; D M MacLaren
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.